Archford Capital Strategies’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,466
| Closed | -$451K | – | 258 |
|
|
2023
Q3 | $451K | Sell |
6,466
-156
| -2% | -$11.1K | 0.09% | 203 |
|
|
2023
Q2 | $503K | Sell |
6,622
-89
| -1% | -$6.33K | 0.1% | 209 |
|
|
2023
Q1 | $522K | Sell |
6,711
-4
| -0.1% | -$335 | 0.11% | 197 |
|
|
2022
Q4 | $626K | Buy |
6,715
+75
| +1% | +$7.24K | 0.14% | 170 |
|
|
2022
Q3 | $633K | Buy |
6,640
+76
| +1% | +$7.52K | 0.16% | 153 |
|
|
2022
Q2 | $608K | Buy |
6,564
+949
| +17% | +$92.6K | 0.15% | 165 |
|
|
2022
Q1 | $558K | Buy |
5,615
+2
| +0% | +$210 | 0.12% | 170 |
|
|
2021
Q4 | $579K | Sell |
5,613
-98
| -2% | -$9.06K | 0.13% | 167 |
|
|
2021
Q3 | $485K | Buy |
5,711
+476
| +9% | +$39.9K | 0.11% | 191 |
|
|
2021
Q2 | $437K | Sell |
5,235
-246
| -4% | -$20.1K | 0.11% | 195 |
|
|
2021
Q1 | $415K | Buy |
5,481
+1,445
| +36% | +$105K | 0.11% | 200 |
|
|
2020
Q4 | $302K | Sell |
4,036
-486
| -11% | -$31.6K | 0.07% | 233 |
|
|
2020
Q3 | $264K | Sell |
4,522
-554
| -11% | -$34.5K | 0.07% | 224 |
|
|
2020
Q2 | $330K | Sell |
5,076
-390
| -7% | -$24.6K | 0.1% | 199 |
|
|
2020
Q1 | $324K | Sell |
5,466
-493
| -8% | -$32.9K | 0.13% | 173 |
|
|
2019
Q4 | $443K | Sell |
5,959
-560
| -9% | -$39.3K | 0.15% | 169 |
|
|
2019
Q3 | $411K | Sell |
6,519
-479
| -7% | -$28.4K | 0.15% | 169 |
|
|
2019
Q2 | $381K | Sell |
6,998
-1,100
| -14% | -$59.2K | 0.14% | 175 |
|
|
2019
Q1 | $437K | Buy |
8,098
+343
| +4% | +$21.2K | 0.16% | 168 |
|
|
2018
Q4 | $508K | Sell |
7,755
-647
| -8% | -$48.3K | 0.2% | 140 |
|
|
2018
Q3 | $661K | Sell |
8,402
-667
| -7% | -$47.7K | 0.24% | 121 |
|
|
2018
Q2 | $584K | Buy |
9,069
+8,202
| +946% | +$541K | 0.21% | 138 |
|
|
2018
Q1 | $63K | Buy |
+867
| New | +$62.2K | 0.03% | 192 |
|
|
2017
Q4 | – | Sell |
-15,863
| Closed | -$1.29M | – | 189 |
|
|
2017
Q3 | $1.29M | Sell |
15,863
-3,173
| -17% | -$251K | 0.48% | 69 |
|
|
2017
Q2 | $1.53M | Sell |
19,036
-905
| -5% | -$71.5K | 0.61% | 53 |
|
|
2017
Q1 | $1.56M | Sell |
19,941
-1,822
| -8% | -$145K | 0.59% | 50 |
|
|
2016
Q4 | $1.72M | Buy |
21,763
+8,970
| +70% | +$726K | 0.72% | 38 |
|
|
2016
Q3 | $1.14M | Buy |
12,793
+364
| +3% | +$34.4K | 0.47% | 68 |
|
|
2016
Q2 | $1.19M | Buy |
12,429
+125
| +1% | +$12.5K | 0.63% | 46 |
|
|
2016
Q1 | $1.28M | Buy |
12,304
+275
| +2% | +$26.7K | 0.61% | 50 |
|
|
2015
Q4 | $1.18M | Buy |
12,029
+1,352
| +13% | +$132K | 0.54% | 52 |
|
|
2015
Q3 | $1.03M | Sell |
10,677
-38
| -0.4% | -$4K | 0.77% | 32 |
|
|
2015
Q2 | $1.12M | Buy |
10,715
+9,456
| +751% | +$966K | 0.8% | 30 |
|
|
2015
Q1 | $1.02M | Sell |
1,259
-10,050
| -89% | -$1.02M | 0.7% | 45 |
|
|
2014
Q4 | $1.09M | Buy |
11,309
+807
| +8% | +$71.1K | 0.8% | 31 |
|
|
2014
Q3 | $836K | Sell |
10,502
-1,269
| -11% | -$100K | 0.66% | 41 |
|
|
2014
Q2 | $887K | Buy |
11,771
+157
| +1% | +$11.9K | 0.69% | 40 |
|
|
2014
Q1 | $869K | Buy |
+11,614
| New | +$820K | 0.73% | 35 |
|
Other funds holding CVS
Archford Capital Strategies's CVS Position: Q4 2023 in Review
Archford Capital Strategies sold out of CVS Health (CVS) in Q4 2023, closing a stake of 6,466 shares — an estimated $451K sold.
Archford Capital Strategies first reported a position in CVS in Q1 2014 and held it in 38 quarters. The position peaked at $1.72M in Q4 2016. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.
- Archford Capital Strategies reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
- Archford Capital Strategies sold 6,466 CVS Health shares in Q4 2023, an estimated $451K.
- Archford Capital Strategies first reported a position in CVS Health in Q1 2014 and held it in 38 quarters.
- Archford Capital Strategies's CVS Health position peaked at $1.72M in Q4 2016.
- 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.
Based on Archford Capital Strategies's 13F filing for Q4 2023, filed 12 Jan 2024.